Navigation Links
Collaboration offers NIH Clinical Center resources to Damon Runyon clinical investigators
Date:12/21/2010

A new pilot partnership between the National Institutes of Health Clinical Center, the National Cancer Institute's Center for Cancer Research, and the Damon Runyon Cancer Research Foundation will offer some of the capabilities and expertise of America's research hospital to an external group of clinical investigators in cancer research. The special talent and resources of the NIH will allow Damon Runyon-funded investigators to undertake studies and collaborations that will advance understanding of the prevention, diagnosis, and treatment of cancer.

Damon Runyon Clinical Investigators (DRCIs) are early career physician-scientists whose focus is on the translation of basic science discoveries into practical therapies. Since 1946, the Damon Runyon Cancer Research Foundation has invested more than $230 million in early career cancer researchers who have the energy, drive, and creativity to become leading innovators in their fields.

"Thanks to the new three-component partnership, these young investigators can apply to use certain equipment, facilities, and patient cohorts at the Clinical Center in research collaborations with NIH clinician-scientists," said John I. Gallin, M.D., Clinical Center director.

An approved research proposal could also provide access to select research materials, services, or products that may not be available or possible at their home institutions such as products from the Pharmacy Department's Pharmaceutical Development Facility through arrangements with the Clinical Center but without a formal research collaboration with a specific institute.

If the pilot proves successful, the NIH and the Clinical Center may pursue similar partnerships with other NIH institutes and centers and external organizations.

"This is a first step toward opening the doors of the Clinical Center to a new band of clinician-scientists, further supporting the NIH mission to enhance health and reduce the burden of disease," said Gallin. The partnership allows DRCIs to partner with an NIH-tenured or tenure-track investigator on a research project. If the NIH research partner is not identified independently, the DRCI can submit a research proposal to the National Cancer Institute and the Clinical Center for assistance in naming a suitable collaborator.

A scientist applying for a Damon Runyon Cancer Research Foundation Clinical Investigator Award could apply with a mentor from the National Cancer Institute or another NIH institute or center. The application would identify the research to be done and the resources used at the Clinical Center.

"We are thrilled to offer these opportunities and resources to the clinical investigators we fund," said Lorraine Egan, executive director of the Damon Runyon Cancer Research Foundation. To facilitate these partnerships, the Clinical Center and the National Cancer Institute's Center for Cancer Research will create an annually updated portfolio of ongoing research and of the research interests of NIH investigators.

In addition to scientific collaborations, this pilot partnership will provide interested DRCIs opportunities to participate in the Clinical Center's clinical research training curriculum. Courses are Introduction to the Principles and Practice of Clinical Research, Principles of Clinical Pharmacology, and Ethical and Regulatory Aspects of Clinical Research. Furthermore, DRCIs are invited to apply to the Clinical Center Sabbatical in Clinical Research Management.


'/>"/>

Contact: Yung S. Lie
yung.lie@damonrunyon.org
212-455-0521
Damon Runyon Cancer Research Foundation
Source:Eurekalert

Related medicine news :

1. AIUM spearheads collaboration to develop guidelines for point-of-care ultrasound applications
2. Hutchinson Center and China CDC sign agreement for research and training collaboration
3. Hospital Collaboration May Boost Surgical Patient Safety
4. Mayo collaboration finds source of breast drug side effect
5. Novel nanotechnology collaboration leads to breakthrough in cancer research
6. Pfizer joins open-access medicinal chemistry public-private collaboration
7. Expert Insights on Health Data Sharing, Collaboration, Quality and Meaningful Use Featured in Latest Carefx Position Paper
8. ECOSTASY™ Sustainable Design Destination Launches Collaboration with 2010 International Year of Biodiversity
9. VRMeetings, Inc. Deploys the most Advanced Web-Based Video Conferencing and Document Collaboration Service over the Managed NTT America IT Infrastructure
10. Johns Hopkins School of Medicine enters collaboration with New York Stem Cell Foundation
11. European collaboration seeks to create World Wide Web for robots
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... report to their offering. ... kidney failure, it replaces the function of kidneys by removing ... thus the treatment helps to keep the patient body,s electrolytes ... Increasing number of ESRD patients & substantial healthcare expenditure ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
Breaking Medicine Technology: